Literature DB >> 206203

Treatment of a murine cytomegalovirus infection with exogenous interferon, polyinosinic-polycytidylic acid, and polyinosinic-polycytidylic acid-poly-L-lysine complex.

E R Kern, G A Olsen, J C Overall, L A Glasgow.   

Abstract

Treatment of a cytomegalovirus infection of mice with exogenous murine interferon did not alter final mortality or mean day of death. Pretreatment with two interferon inducers significantly reduced mortality, but treatment initiated after infection was not effective.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 206203      PMCID: PMC352239          DOI: 10.1128/AAC.13.2.344

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  15 in total

1.  Efficacy of exogenous interferon treatment initiated after onset of multiplication of vesicular stomatitis virus in the brains of mice.

Authors:  I Gresser; M G Tovey; C Bourali-Maury
Journal:  J Gen Virol       Date:  1975-06       Impact factor: 3.891

Review 2.  Effect of interferon on systemic herpesvirus infections.

Authors:  E R Kern; L A Glasgow
Journal:  Tex Rep Biol Med       Date:  1977

3.  Murine cytomegalovirus: induction of and sensitivity to interferon in vitro.

Authors:  H K Oie; J M Easton; D V Ablashi; S Baron
Journal:  Infect Immun       Date:  1975-11       Impact factor: 3.441

4.  Effect of cytosine arabinoside and 5-iodo-2'-deoxyuridine on a cytomegalovirus infection in newborn mice.

Authors:  D K Kelsey; E R Kern; J C Overall; L A Glasgow
Journal:  Antimicrob Agents Chemother       Date:  1976-03       Impact factor: 5.191

5.  Herpesvirus hominis infection in newborn mice: treatment with interferon inducer polyinosinic-polycytidylic acid.

Authors:  E R Kern; J C Overall; L A Glasgow
Journal:  Antimicrob Agents Chemother       Date:  1975-06       Impact factor: 5.191

6.  Susceptibility of clinical isolates of cytomegalovirus to human interferon.

Authors:  B Postic; J N Dowling
Journal:  Antimicrob Agents Chemother       Date:  1977-04       Impact factor: 5.191

7.  Effect of treatment with exogenous interferon, polyinosinic acid-polyctyidylic acid or polyinosinic acid-polycytidylic acid-poly-L-lysine complex on encephalomyocarditis virus infections in mice.

Authors:  G A Olsen; E R Kern; L A Glasgow; J C Overall
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

8.  Effective antiviral chemotherapy in cytomegalovirus infection of mice.

Authors:  J C Overall; E R Kern; L A Glasgow
Journal:  J Infect Dis       Date:  1976-06       Impact factor: 5.226

9.  Effect of human exogenous leukocyte interferon in cytomegalovirus infections.

Authors:  G Emödi; R O'Reilly; A Müller; L K Everson; U Binswanger; M Just
Journal:  J Infect Dis       Date:  1976-06       Impact factor: 5.226

10.  Effect of leukocyte interferon on urinary excretion of cytomegalovirus by infants.

Authors:  A M Arvin; A S Yeager; T C Merigan
Journal:  J Infect Dis       Date:  1976-06       Impact factor: 5.226

View more
  8 in total

Review 1.  Modulation of host innate and adaptive immune defenses by cytomegalovirus: timing is everything.

Authors:  A Loewendorf; C A Benedict
Journal:  J Intern Med       Date:  2010-05       Impact factor: 8.989

Review 2.  Sources and signals regulating type I interferon production: lessons learned from cytomegalovirus.

Authors:  Shilpi Verma; Chris A Benedict
Journal:  J Interferon Cytokine Res       Date:  2011-01-12       Impact factor: 2.607

Review 3.  Animal cytomegaloviruses.

Authors:  J Staczek
Journal:  Microbiol Rev       Date:  1990-09

Review 4.  Molecular biology and immunology of cytomegalovirus.

Authors:  P D Griffiths; J E Grundy
Journal:  Biochem J       Date:  1987-01-15       Impact factor: 3.857

5.  Cytomegalovirus induces interferon-stimulated gene expression and is attenuated by interferon in the developing brain.

Authors:  Anthony N van den Pol; Michael D Robek; Prabhat K Ghosh; Koray Ozduman; Prasanthi Bandi; Matthew D Whim; Guido Wollmann
Journal:  J Virol       Date:  2006-10-25       Impact factor: 5.103

6.  Effects of immunosuppression with cyclophosphamide on acute murine cytomegalovirus infection and virus-augmented natural killer cell activity.

Authors:  M K Selgrade; M J Daniels; P C Hu; F J Miller; J A Graham
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

7.  Therapeutic effect of acyclovir (ZoviraxTM) on the pathogenesis of chronic murine cytomegalovirus infection in the immunodeficient nude mouse.

Authors:  P Carthew
Journal:  Br J Exp Pathol       Date:  1982-12

8.  Evidence for a protective role of interferon in resistance to murine cytomegalovirus and its control by non-H-2-linked genes.

Authors:  J E Grundy; J Trapman; J E Allan; G R Shellam; C J Melief
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.